Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents

Journal of Neuroscience

Volumn 16, Issue 20, 1996, Pages 6592-6600

  Fadel, Jim ^a   Moore, Holly ^a   Sarter, Martin ^a   Bruno, John P ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

192 IgG saporin; acetylcholine; benzodazepine receptor; cortex; deafferentation; inverse agonist; lesion; microdialysis

Indexed keywords

5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; ACETYLCHOLINE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN G; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; SAPORIN; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEAFFERENTATION; DEMENTIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029794368     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-20-06592.1996     Document Type: Article

References (61)

1. Bertorelli R, Forloni GL, Consolo S (1991) Modulation of cortical in vivo acetylcholine release by the basal nuclear complex: role of the pontomesencephalic tegmental area. Brain Res 563:353-356.
2. Bowen DM, Smith CB, White P, Davidson AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:457-496.
3. Bruno JP, Miller JA (1994) Inhibition of GABAergic transmission: interactions with other transmitter systems. In: Benzodiazepine receptor inverse agonists (Sarter M, Nutt DJ, Lister RG, eds), pp 41-82. New York: Wiley.
4. Butcher LL, Woolf NJ (1986) Central cholinergic systems: synopsis of anatomy and overview of physiology and pathology. In: The biological substrates of Alzheimer's disease (Scheibel AB, Wechsler AF, eds), pp 73-86. New York: Academic.
5. Cossette P, Umbriaco D, Zamar N, Hamel E, Descarries L (1993) Recovery of choline acetyltransferase activity without sprouting of the residual acetylcholine innervation in adult rat cerebral cortex after lesion of the nucleus basalis. Brain Res 630:195-206.
6. Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-168.
7. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesberry WR (1992) Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 32:625-632.
8. Drachman DA (1978) Central cholinergic system and memory. In: Psychopharmacology: a generation of progress (Lipton MA, DiMascio A, Killam KF, eds), pp 651-661. New York: Raven.
9. Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam MM (1994) Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14:1271-1289.
10. Herrera-Marschitz H, Goiny M, Utsumi H, Ferre S, Hakansson L, Nordberg A, Ungerstedt U (1990) Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neurosci Lett 110:172-179.
11. Holley LA, Miller JA, Chmielewski PA, Dudchenko P, Sarter M (1993) Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission. Brain Res 610:181-193.
12. Holley LA, Wiley RG, Lappi DA, Sarter M (1994) Cortical cholinergic deafferentation following the intracortical infusion of 192 IgG-saporin: a quantitative histochemical study. Brain Res 663:277-286.
13. Inglis FM, Day JC, Fibiger HC (1994) Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience 62:1049-1056.
14. Inglis FM, Fibiger HC (1995) Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 66:81-86.
15. Jensen LH, Petersen EN, Breastrup C, Honore T, Kehr W, Seidelmann D, Schmiechen R (1984) Evaluation of the β-carboline ZK 93,426 as a benzodiazepine receptor antagonist. Psychopharmacology (Berl) 83:249-256.
16. Johnson BJ, Bruno JP (1995) Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. Neuropharmacology 34:191-203.
17. 3H]Vesamicol binding in human brain cholinergic deficiency disorders. Neurosci Lett 117:347-352.
18. Kurosawa M, Sato A, Sato Y (1989) Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats. Neurosci Lett 98:45-50.
19. McCullough LD, Salamone JD (1992) Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens. Psychopharmacology (Berl) 109:382-397.
20. McGaughy J, Kaiser T, Sarter M (1996) Behavioral vigilance following the infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110:247-265.
21. A receptor. In: Benzodiazepine receptor inverse agonists (Sarter M, Nutt DJ, Lister RG, eds), pp 25-41. New York: Wiley.
22. Moore H, Sarter M, Bruno JP (1992) Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 596:17-29.
23. Moore H, Sarter M, Bruno JP (1993) Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 627:267-274.
24. Moore H, Sarter M, Bruno JP (1995a) Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain. Neurosci Lett 189:31-34.
25. Moore H, Stuckman S, Sarter M, Bruno JP (1995b) Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling. Synapse 21:324-331.
26. Moore H, Fadel J, Sarter M, Bruno JP (1995c) Interactions between benzodiazepine and dopamine receptors in the modulation of cortical acetylcholine release. Soc Neurosci Abstr 21:763.2.
27. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611-622.
28. Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313-2326.
29. Palmer AM, Francis PT, Benton SJ, Sims NR, Mann DMA, Neary D, Snowdon JS, Bowen DM (1987a) Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem 48:8-15.
30. Palmer AM, Francis PT, Bowen DM, Benton JS, Neary D, Mann DMA, Snowdon JS (1987b) Catecholaminergic neurons assessed antemortem in Alzheimer's disease. Brain Res 414:365-375.
31. Pascual J, Fontan A, Zarranz JJ, Berciano J, Florez J, Pazos A (1991) High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Res 552:170-174.
32. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1:189.
33. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH (1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13:393-400.
34. Potter PE, Meek JL, Neff NH (1983) Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J Neurochem 41:133-194.
35. Rasmusson D, Clow K, Szerb JC (1992) Frequency-dependent increase in cortical acetylcholine release evoked by stimulation of the nucleus basalis magnocellularis in the rat. Brain Res 594:1501-1554.
36. Robbins TW, Everitt BJ, Marston HM, Wilkinson J, Jones GH, Page KJ (1989) Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav Brain Res 35:221-240.
37. Robner S, Perez-Polo JR, Wiley RG, Schliebs R, Bigl V (1994) Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system. J Neurosci Res 38:282-293.
38. Robner S, Schliebs R, Hartig W, Bigl V (1995) 192 IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res Bull 38:371-381.
39. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology (Berl) 110:395-401.
40. Sarter M, Bruno JP (1994) Cognitive functions of cortical acetylcholine: lessons from studies on the transsynaptic modulation of activated efflux. Trends Neurosci 17:217-221.
41. Sarter M, Bruno JP (1996a) Transsynaptic stimulation of cortical acetylcholine and attention: a rational approach for the development of cognition enhancers. Behav Brain Res, in press.
42. Sarter M, Bruno JP (1996b) Cortical acetylcholine, attention, and neuropharmacological and cognitive principles of a rational development of treatment strategies for cognitive disorders. In: Alzheimer's disease: molecular aspects and pharmacological treatments (Brioni JE, Decker MW, eds). New York: Wiley, in press.
43. Sarter M, Steckler T (1989) Spontaneous exploration of a 6-arm radial tunnel maze by basal forebrain lesioned rats: effects of the benzodiazepine receptor antagonist β-carboline ZK 93426. Psychopharmacology (Berl) 98:193-202.
44. Sarter M, Schneider HH, Stephens DN (1988) Treatment strategies in senile dementia: antagonist β-carbolines. Trends Neurosci 11:13-17.
45. Sarter M, Bruno JP, Dudchenko P (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology (Berl) 101:1-17.
46. Sarter M, McGaughy J, Holley LA, Dudchenko PA (1994) Behavioral facilitation and cognition enhancement. In: Benzodiazepine receptor inverse agonists (Sarter M, Nutt DJ, Lister RG, eds), pp 213-242. New York: Wiley.
47. Sarter M, Bruno JP, Givens BS, Moore H, McGaughy J, McMahon K (1996) Neuronal mechanisms of drug effects on cognition: cognitive activity as a necessary intervening variable. Cog Brain Res, in press.
48. Sillito AM, Murphy PC (1987) The cholinergic modulation of cortical function. In: Cerebral cortex, Vol 6 (Jones EG, Peters A, eds), pp 161-185. New York: Plenum.
49. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) . Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503-509.
50. Soares JC, Gershon S (1995) THA-historical aspects, review of pharmacological properties and therapeutic effects. Dementia 6:255-234.
51. Szerb JC, Clow K, Rasmusson DD (1994) Pharmacological but not physiological modulation of cortical acetylcholine release by cholinergic mechanism in the nucleus basalis magnocellularis. Can J Physiol Pharmacol 72:893-898.
52. Tago H, Kimura H, Maeda T (1986) Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 34:1431-1438.
53. Torres EM, Perry TA, Blokland A, Wilkinson LS, Wiley RG, Lappi DA, Dunnett SB (1994) Behavioural histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 63:95-122.
54. Traub M, Friedman SB (1992) The implication of current therapeutic approaches for cholinergic hypothesis of dementia. Dementia 3:189-192.
55. Turchi J, Bruno JP, Sarter M (1995) Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on cross-modal divided attention in rats. Soc Neurosci Abstr 21:763.9.
56. Tyrefors N, Carlsson A (1990) Improvements in the separation and detection of acetylcholine and choline using liquid chromatography and electrochemical detection. J Chromatogr 502:337-339.
57. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167-186.
58. Wenk GK, Stoehr JD, Quintana G, Mobley S, Wiley RG (1994) Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 14:5986-5995.
59. Whitehouse PJ, Price DL, Struble RG, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
60. Wiley RG (1992) Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci 15:285-290.
61. Wiley RG, Lappi DA (1993) Preparation of anti-neuronal immunotoxins for selective neural immunolesioning. In: Neuroscience protocols (Floris G, ed), pp 275-324. Amsterdam: Elsevier.